Onconova Therapeutics Balance Sheet - Quarterly (NASDAQ:ONTX)

Add to My Stocks
$0.49 $0.01 (2%) ONTX stock closing price Sep 21, 2018 (Closing)

The financial analysis of a company like Onconova Therapeutics involves checking the three financial statements of the company in detail, of which the balance sheet is one. Financial strength can be guaged by performing Onconova Therapeutics stock analysis and by analyzing the balance sheet. Quarterly results are typically accompanied with the company releasing financial statements. Apart from analyzing Onconova Therapeutics revenue Onconova Therapeutics operating cash flow, one needs to check balance sheet items like cash, fixed assets and debt. The Onconova Therapeutics balance sheet for 2018 Q2 shows cash on hand of $29.54M. The company has a debt to equity ratio of 0.

View and download Onconova Therapeutics quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Cash29.54M7.26M4.02M7.65M15.03M15.43M21.45M25.82M12.86M16.88M
Marketable Securities----------
Receivables--------2.14M1.36M
Inventory----------
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets---1M--1.58M1.16M-1.15M
Total Current Assets
30.15M8.55M4.9M8.7M15.98M16.41M23.06M27.9M15.99M19.4M
Property Plant & Equipment2.22M2.22M2.22M2.22M2.22M2.22M2.22M2.22M2.22M2.22M
Accumulated Depreciation2.19M2.18M2.16M2.14M2.12M2.09M2.07M2.05M2.02M2M
Net Property Plant & Equipment
----------
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Intangibles----------
Deposits & Other Assets----------
Total Assets
30.2M8.61M4.97M8.8M16.1M16.55M23.23M28.08M16.2M19.64M
Notes Payable----------
Accounts Payable5.94M7.03M6.18M5.43M5.68M5.4M5.32M4.07M2.8M3.29M
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses3.57M3.06M3.33M3.09M3.72M4.02M4.38M4.48M5.83M3.89M
Income Taxes Payable----------
Other Current Liabilities----------
Total Current Liabilities
9.97M10.55M9.97M8.98M9.86M9.88M10.16M9M9.09M7.64M
Mortgages----------
Deferred Taxes/Income3.86M3.97M4.09M4.2M4.31M4.43M4.54M4.65M4.77M4.88M
Convertible Debt----------
Long-Term Debt----------
Non-Current Capital Leases----------
Other Long-Term Liabilities--1.77M1.68M1.47M4.95M3.4M4.4M--
Total Liabilities
14.28M15.49M15.84M14.88M15.65M19.26M18.1M18.07M14.15M12.82M
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus385.96M359.49M350.51M349.1M348.67M342.98M342.48M341.91M332.38M331.52M
Retained Earnings-370.89M-367.4M-362.31M-356.1M-349.14M-346.56M-338.22M-332.77M-331.17M-325.79M
Treasury Stock----------
Other Liabilities-0.01M---------
Shareholders Equity15.91M-6.87M-10.86M-6.07M--2.71M5.12M10.01M2.04M6.81M
Total Liabilities & Shareholders Equity30.2M8.61M4.97M8.8M16.1M16.55M23.23M28.08M16.2M19.64M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Click here to view our Celgene financial analysis

Most investors just check the Onconova Therapeutics stock price, and Onconova Therapeutics historical stock prices before investing. While share price is an important factor, one should also look at financials and valuation metrics like the Onconova Therapeutics PE ratio chart. Below is a brief explanation of common balance sheet terms:

  • Assets: An asset is a resource that a corporation like Onconova Therapeutics owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for ONTX stock as of 2018 Q2 is $30.2M. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities or obligations comprise of current liabilities that include short term loans, amounts payable to suppliers, or any other outstanding payments including long term liabilities that take into account long term loans for funding large projects. The total liabilities for Onconova Therapeutics is $14.28M. Shareholders equity comes under liabilities as it is money the company owes the holders of ONTX stock.

Onconova Therapeutics Balance Sheet - Key Ratios

Current ratio
3.02
Debt to equity ratio
0
Asset turnover ratio
0.1
Receivables turnover
7.47